BIOPOR Bioporto A/S

Updated financial calendar for 2020

Updated financial calendar for 2020

February 26, 2020

Announcement no. 2

Updated financial calendar for 2020

As stated in announcement no. 1 of February 26, 2020, BioPorto has decided to postpone the publication of its Annual Report for 2019 and the Annual General Meeting. Please find the updated financial calendar for 2020 below:

DateDescription
March 2, 2020Deadline for shareholder proposals – Annual General Meeting
March 11, 2020Annual Report 2019 – investor meeting same date at 15:00 CET
April 14, 2020Annual General Meeting
May 7, 2020Interim Report – for the three-month period ended March 31, 2020
August 19, 2020Interim Report – for the six-month period ended June 30, 2020
November 18, 2020Interim Report – for the nine-month period ended September 30, 2020

For further information, please contact:

Ole Larsen, CFO

Telephone , e-mail:

About BioPorto

BioPorto is an in vitro diagnostics company that provides tests and antibodies to clinicians and researchers around the world. We use our antibody and assay expertise to transform novel research tools into clinically actionable biomarkers that can make a difference in patients’ lives. BioPorto is headquartered in Hellerup, Denmark and is listed on the NASDAQ Copenhagen stock exchange [CPH:BIOPOR].

Attachment

EN
26/02/2020

Underlying

BIOPORBioporto A/S

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Bioporto A/S

 PRESS RELEASE
Free
BIOPOR BIOPORTO A/S

Fortsat fremgang på vigtige strategiske milepæle i første kvartal af 2...

Fortsat fremgang på vigtige strategiske milepæle i første kvartal af 2025. Den samlede omsætning er i overensstemmelse med forventningerne, og guidance for 2025 fastholdes. 8. maj 2025Meddelelse nr. 15                                                                          Fortsat fremgang på vigtige strategiske milepæle i første kvartal af 2025. Den samlede omsætning er i overensstemmelse med forventningerne, og guidance for 2025 fastholdes. Delårsresultat og en forretningsstatus for første kvartal 2025 København, Danmark, 8. maj 2025, (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto eller S...

May 8, 2025 1 EN
 PRESS RELEASE
Free
BIOPOR BIOPORTO A/S

Continued progress on key strategic milestones in Q1 2025. Total reven...

Continued progress on key strategic milestones in Q1 2025. Total revenue in line with expectations and guidance for 2025 maintained. May 8, 2025Announcement no. 15                                                                          Continued progress on key strategic milestones in Q1 2025. Total revenue in line with expectations and guidance for 2025 maintained. Interim results and a business update for the first quarter of fiscal 2025 Copenhagen, Denmark, May 8, 2025, (GLOBE NEWSWIRE) – BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR) today announced interim financial resul...

May 8, 2025 1 EN
 PRESS RELEASE
Free
BIOPOR BIOPORTO A/S

Tildeling af Warrants

Tildeling af Warrants 28. april 2025Meddelelse nr. 14                                                                          Tildeling af Warrants København, Danmark, den 28. april 2025 (GLOBE NEWSWIRE) – Bestyrelsen for BioPorto A/S ("BioPorto" eller "Selskabet") (CPH:BIOPOR) har i dag implementeret beslutningen fra den ordinære generalforsamling afholdt den 11. april 2025 om at udstede i alt 1.700.000 warrants som en del af vederlaget til medlemmerne af Selskabets bestyrelse. Hver warrant giver indehaveren ret til at tegne én aktie i BioPorto til en udnyttelseskurs på 1.50 kr. pr. a...

April 28, 2025 1 EN
 PRESS RELEASE
Free
BIOPOR BIOPORTO A/S

Grant of Warrants

Grant of Warrants April 28, 2025Announcement no. 14                                                                          Grant of Warrants Copenhagen, Denmark, April 28, 2025, (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR) has today implemented the resolution of the annual general meeting held on April 11, 2025 to issue a total of 1,700,000 warrants as part of the remuneration to members of the Board of Directors of the Company. Each warrant entitles the holder the right to subscribe for one share in BioPorto at an exercise price...

April 28, 2025 1 EN
 PRESS RELEASE
Free
BIOPOR BIOPORTO A/S

Managers’ transactions

Managers’ transactions April 25, 2025Announcement no. 13                                                                          Managers’ transactions In connection with the completion of BioPorto A/S’ directed issue as described in company announcement no. 12, BioPorto A/S has received notification pursuant to article 19 of Regulation (EU) no. 596/2014 of the below transactions related to shares in BioPorto A/S made by persons discharging managerial responsibilities in BioPorto A/S and/or persons closely associated with them. 1 Details of the person discharging managerial responsibili...

April 25, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch